UPLD 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-05-01

• You should not rely upon forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Quarterly Report on Form 10-Q primarily on our current expectations and projections about future events and trends that we believe may affect our busine…

• Weighted-average common shares outstanding, basic and diluted29,159,015 28,220,936

• (2) Includes general and administrative stock-based compensation of $0.8 million and $2.0 million for the three months ended March 31, 2026 and March 31, 2025, respectively. General and administrative expense excluding stock-based compensation as a percentage of total revenues was 16% and 15% for th…

• (3) Includes depreciation and amortization of $1.0 million and $1.7 million for the three months ended March 31, 2026 and March 31, 2025, respectively.

• Total revenue was $48.7 million in the three months ended March 31, 2026, compared to $63.7 million in the three months ended March 31, 2025, a decrease of $15.0 million, or 24%. This decrease is primarily due to the expected declines in revenue related to divested product lines of $14.0 million and…

相对上期删除的文字 · 来源:10-Q · 2025-11-06

• •our financial performance and our ability to achieve or sustain profitability or predict future results;

• •our plans regarding future acquisitions or divestitures and our ability to consummate and operationalize acquisitions or divestitures;

• •our ability to expand our go to market operations, including our marketing and sales organization, and successfully increase sales of our products;

• •our ability to obtain financing in the future on acceptable terms or at all;

• •our expectations with respect to revenue, cost of revenue and operating expenses in future periods;

相对上期新增的文字 · 来源:10-Q · 2026-05-01

• As a "smaller reporting company" as defined by Item 10 of Regulation S-K, the Company is not required to provide the information required by this Item.

相对上期删除的文字 · 来源:10-Q · 2025-11-06

• We have operations both within the United States and internationally, and we are exposed to market risks in the ordinary course of our business. These risks primarily include interest rate, foreign exchange and inflation risks, as well as risks relating to changes in the general economic conditions …

• Our exposure to market risk for changes in interest rates primarily relates to our cash equivalents and variable rate indebtedness.

• The primary objective of our investment activities is to preserve principal while maximizing yields without significantly increasing risk. This objective is accomplished currently by making diversified investments, consisting only of money market mutual funds and FDIC insured institutional liquid de…

• Our Credit Agreement bears interest at the secured overnight financing rate, which shall not be less than 1.50%, plus a margin of 6.00% per annum (with step downs and a potential step up at specified leverage levels). We have an interest rate cap to limit the interest rate risk exposure and effectiv…

• As of September 30, 2025, we had an outstanding balance of $240.0 million under our Credit Agreement that matures in July 2031. Based on our outstanding balance of variable rate debt at September 30, 2025, a hypothetical change of 100 basis points could have resulted in a $0.6 million increase to to…

相对上期删除的文字 · 来源:10-Q · 2025-11-06

• Internal control over financial reporting cannot provide absolute assurance of achieving financial reporting objectives because of its inherent limitations. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment and br…

相对上期新增的文字 · 来源:10-Q · 2026-05-01

• Our failure to meet the continued listing requirements of Nasdaq could result in a delisting of our common stock, which could negatively impact the market price and liquidity of our common stock and our ability to access the capital markets.

• Our common stock is listed on the NASDAQ Global Market, or Nasdaq. In order to maintain this listing, we must satisfy the continued listing requirements and standards of Nasdaq, including a minimum closing bid price requirement for our common stock of $1.00 per share. On April 7, 2026, we received a…

• If the closing bid price of our common stock continues to trade below $1.00 per share, we intend to implement a reverse stock split to attempt to regain compliance, as disclosed in our definitive proxy statement filed with the SEC on April 20, 2026. However, a reverse stock split requires stockholde…

• If we are unable to regain compliance within the applicable cure period, including any available extension, our common stock would be subject to delisting from Nasdaq. Further, even if we regain compliance, we may not be able to sustain compliance with Rule 5450(a)(1) in the long term. A delisting c…

相对上期新增的文字 · 来源:10-Q · 2026-05-01

• On March 9, 2026, Timothy Mattox, who serves on the Company’s Board of Directors, adopted a written plan for the sale of up to 58,481 shares of the Company’s Common Stock that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. The written plan will ex…

• During the three months ended March 31, 2026, none of our other officers (as defined in Rule 16a-1(f)) or directors adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K under the Securities Act).

相对上期删除的文字 · 来源:10-Q · 2025-11-06

• During the three months ended September 30, 2025, none of our officers (as defined in Rule 16a-1(f)) or directors adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K under the Securities Act).